Skip to main content
Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
198.83
-0.36 (-0.18%)
At close: Dec 5, 2025, 4:00 PM EST
198.84
+0.01 (0.01%)
After-hours: Dec 5, 2025, 7:53 PM EST

Cardinal Health Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
215.84B 204.62B 204.83B 205.05B 207.77B 210.79B 204.88B 201.03B
Pharmaceutical Growth
3.88% -2.92% -0.02% 2.00% 6.45% 10.93% 11.56% 13.07%
Medical
12.74B 12.68B 12.59B 12.55B 13.27B 13.91B 14.56B 15.13B
Medical Growth
-3.99% -8.82% -13.49% -17.07% -11.49% -7.35% -3.14% -0.66%

Profit by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
2.40B 2.26B 2.21B 2.12B 2.11B 2.09B 2.11B 2.13B
Pharmaceutical Growth
13.51% 8.19% 4.55% -0.28% 1.69% 4.40% 8.38% 16.15%
Medical
657.00M 135.00M 112.00M 93.00M 146.00M 209.00M 244.00M 244.00M
Medical Growth
350.00% -35.41% -54.10% -61.89% -23.16% 88.29% 1,776.92% 369.23%

Profit Margin by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Medical
1.44% 2.20% 1.23% 0.56% 0.26% 1.51% 0.64% 1.81%
Pharmaceutical
1.13% 0.96% 1.31% 1.04% 1.10% 0.87% 1.15% 0.97%

Operating Expense Breakdown
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Distribution, Selling, General, and Administrative
5.57B 5.38B 5.18B 5.14B 5.12B 5.04B 5.03B 4.93B
Distribution, Selling, General, and Administrative Growth
8.73% 6.81% 2.90% 4.38% 5.90% 4.24% 6.50% 5.26%
Amortization and Other Acquisition-Related Costs
494.00M 464.00M 408.00M 336.00M 294.00M 284.00M 276.00M 270.00M
Amortization and Other Acquisition-Related Costs Growth
68.03% 63.38% 47.83% 24.44% 5.76% -0.35% -8.91% -12.34%
Restructuring and Employee Severance
84.00M 88.00M 130.00M 155.00M 174.00M 175.00M 139.00M 102.00M
Restructuring and Employee Severance Growth
-51.72% -49.71% -6.47% 51.96% 91.21% 84.21% 29.91% -16.39%
Impairments and (Gain)/Loss on Disposal of Assets, Net
21.00M 18.00M -7.00M 94.00M 92.00M 630.00M 989.00M 925.00M - - -
Impairments and (Gain)/Loss on Disposal of Assets, Net Growth
-77.17% -97.14% - -89.84% -94.37% -49.60% -15.40% -42.90% - - -
Litigation Charges, Net
- -185.00M -126.00M 60.00M 80.00M 79.00M -17.00M -174.00M -370.00M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.